France-based pharmaceutical company Ipsen S.A. (EPA: IPN, OTCMKTS: IPSEY) announced the appointment of Olivia Brown as Executive Vice-President (EVP), Global Head of Neurotoxins, effective April 1st, 2025. In her new role, Olivia will lead Ipsen’s global neurotoxins franchise, overseeing strategy and execution across both therapeutic and aesthetic indications.
Olivia Brown’s Background
Olivia brings over 20 years of global leadership experience in pharmaceuticals and medical aesthetics to her new position. Prior to joining Ipsen, she worked with Novartis, where she led the establishment of a new therapeutic area in Allergy & Immunology. Earlier in her career, she held senior leadership positions at Merz Aesthetics and Galderma, where she played a key role in expanding the global neurotoxins market.
Strategic Leadership
As Global Head of Neurotoxins, Olivia will focus on driving growth for Ipsen’s neurotoxins portfolio, which includes both therapeutic and aesthetic products. Her extensive experience in market expansion and strategic leadership will be instrumental in further solidifying Ipsen’s position in the neurotoxins market.-Fineline Info & Tech
Leave a Reply